Disseminated tumor cells (DTCs) shed from a primary tumor may lie dormant in distant tissues for long periods of time before they can be activated to form metastases. Recently work in our group has shown that (i) the engraftment of hematopoietic stem cells (HSC) and (ii) prostate cancer (PCa) metastasis to the marrow are dependent on many of the same molecules. In fact, we have recently demonstrated that metastatic PCa directly competes with HSC for occupancy of the niche. We have also developed technology and models that permits isolation of human DTCs from marrow using anti-human leukocyte antigens (HLA). Hypothesis: Molecules that induce HSC dormancy also induce dormancy of metastatic PCa cells and can be used to identify DTCs. The following aims are proposed: (1) Identify the differences between circulating tumor cells (CTCs) and successful DTCs. Sub Hypothesis: Dormant DTCs have different profiles from CTCs and dividing DTCs. We will determine the expression levels of receptors, known to regulate homing, lodging and growth, and gene expression profiling on CTCs and DTCs that will be obtained from our murine xenograft model. Then, these analyses will be repeated with CTCs and DTCs obtained from PCa patients. (2) Identify the specific subtype of DTCs that become dormant. Sub hypotheses: DTCs that become dormant have the capability to eventually form tumors. First, we will determine the frequency of tumorigenic cells in the dormant DTCs by implanting into immunocompromized mice. Next, we will determine the tumorogenic phenotype while determining if these cells also have the colony-forming ability and chemo-resistant ability. Finally, we will determine if we can manipulate dormant state of these cells with GAS6 (See Project 2) or IL-6 (See Project 3). (3) Determine the molecular mechanism that is critical for DTCs to become dormant. Sub hypotheses: The binding to annexin 2 (AnxaZ) is critical for DTCs to become dormant We have demonstrated that Anxa2 expressed by osteoblasts is a crucial molecule for the niche selection of PCa, This suggests that PCa obtain the signals from the niche through the Anxa2/Anxa2r axis. Therefore, we will determine if blocking Anxa2r on PCa prevents becoming dormant. In addition, we have observed that when PCa bind to Anxa2, the expression of Axl, the receptors for GAS6, is enhanced on the PCa. Thus, we will determine signaling pathway that is involved in the effects of Anxa2 on Axl induction. These findings will directly lend support to Project 2 which will determine how endosteal HSC niche regulates tumor dormancy, and Project 3 which focuses on what leads to activation of the dormant cells.

Public Health Relevance

In prostate cancer, tumor dormancy is a key event for a long-term survival of disseminated tumor cells (DTCs) in the distant tissues. Our proposed investigations will focus on fundamental mechanisms how DTCs become dormant in the bone marrow. The new insights derived from our investigations will be relevant to identify the phenotype of DTCs that is uniquely responsible for tumor relapse, and will lead to develop new traget therapies for metastatic tumors.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA163124-03
Application #
8567739
Study Section
Special Emphasis Panel (ZCA1-SRLB-3)
Project Start
Project End
Budget Start
2013-08-01
Budget End
2014-07-31
Support Year
3
Fiscal Year
2013
Total Cost
$152,240
Indirect Cost
$95,970
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Jung, Younghun; Wang, Jingcheng; Lee, Eunsohl et al. (2015) Annexin 2-CXCL12 interactions regulate metastatic cell targeting and growth in the bone marrow. Mol Cancer Res 13:197-207
Cordeiro-Spinetti, Eric; Taichman, Russell S; Balduino, Alex (2015) The bone marrow endosteal niche: how far from the surface? J Cell Biochem 116:11-Jun
Roca, Hernan; Pande, Manjusha; Huo, Jeffrey S et al. (2014) A bioinformatics approach reveals novel interactions of the OVOL transcription factors in the regulation of epithelial - mesenchymal cell reprogramming and cancer progression. BMC Syst Biol 8:29
Axelrod, Haley; Pienta, Kenneth J (2014) Axl as a mediator of cellular growth and survival. Oncotarget 5:8818-52
Yumoto, Kenji; Berry, Janice E; Taichman, Russell S et al. (2014) A novel method for monitoring tumor proliferation in vivo using fluorescent dye DiD. Cytometry A 85:548-55
Yumoto, Kenji; Eber, Matthew R; Berry, Janice E et al. (2014) Molecular pathways: niches in metastatic dormancy. Clin Cancer Res 20:3384-9
Yang, Kimberline R; Mooney, Steven M; Zarif, Jelani C et al. (2014) Niche inheritance: a cooperative pathway to enhance cancer cell fitness through ecosystem engineering. J Cell Biochem 115:1478-85
Wan, Liling; Hu, Guohong; Wei, Yong et al. (2014) Genetic ablation of metadherin inhibits autochthonous prostate cancer progression and metastasis. Cancer Res 74:5336-47
Shiozawa, Yusuke; McGee, Samantha; Pienta, Michael J et al. (2013) Erythropoietin supports the survival of prostate cancer, but not growth and bone metastasis. J Cell Biochem 114:2471-8
Taichman, Russell S; Patel, Lalit R; Bedenis, Rachel et al. (2013) GAS6 receptor status is associated with dormancy and bone metastatic tumor formation. PLoS One 8:e61873

Showing the most recent 10 out of 18 publications